Valros-ASP Capsule

Valros-ASP Capsule is a combination of two medicines used to prevent heart attack and stroke. This medicine reduces the "bad" cholesterol (LDL) and triglycerides (fats) levels. Moreover, it also decreases the formation of blood clots.

Valros-ASP Capsule should be taken with food to avoid stomach upset. You should take it regularly at evenly spaced intervals as per the schedule prescribed by your doctor. Taking it at the same time every day will help you remember to take it. The dose and duration of treatment will depend on what you are being treated for. Do not stop taking it until you have finished the complete course, even when you feel better. Lifestyle changes like low-fat diet, exercise and not smoking may help this medicine to work better.

Nausea, abdominal pain, headache, and constipation are some common side effects of this medicine.This medicine increases your risk of bleeding, so it is important to be careful while shaving, cutting nails, using sharp objects, or engaging in contact sports (e.g., football, wrestling). Let your doctor know if you notice yellowing of skin, muscle pain or dark urine.

Before taking this medicine, tell your doctor if you have liver or kidney disease or you are suffering from bleeding disorder. You must tell your doctor if you are pregnant, planning pregnancy or breastfeeding. You should also let your healthcare team know all other medicines you are taking as they may affect, or be affected by this medicine.

• Treatment of Prevention of heart attack and stroke

Treatment of Prevention of heart attack and stroke
Valros-ASP Capsule is a combination medicine that is used to prevent heart attack. It contains rosuvastatin that works by reducing the amount of “bad” cholesterol (LDL) and raising the amount of “good” cholesterol (HDL) in blood. High levels of cholesterol can cause narrowing of the blood vessels (atherosclerosis). Lowering the amount of cholesterol reduces the chances of heart diseases and stroke and helps one remain healthier for longer.

Valros-ASP Capsule also contains a blood thinner, aspirin, that prevents the formation of blood clots and the existing ones from growing bigger in size. Take it regularly and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Keep taking it even if you feel well.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Athrovas ASP

• Nausea
• Headache
• Constipation
• Muscle pain
• Weakness

Take this medicine in the dose and duration as advised by your doctor. Valros-ASP Capsule is to be taken with food.

Valros-ASP Capsule is a combination of two medicines: Rosuvastatin and Aspirin, which prevents heart attack and stroke. Rosuvastatin is a lipid-lowering medication that blocks an enzyme required in the body to make cholesterol. It lowers the "bad" cholesterol (LDL), triglycerides and raises the "good" cholesterol (HDL). Aspirin is a non-steroidal anti-inflammatory drug (NSAID) with anti- platelet action. It prevents the platelets from sticking together and decreases the formation of harmful blood clots.

• You have been prescribed Valros-ASP Capsule to lower your risk of heart attack and stroke.

• Take it with food to avoid an upset stomach.

• Notify your doctor if you are more tired than usual, do not feel hungry, or if you have yellow eyes, skin.

• Notify your doctor if you experience muscle symptoms (pain or weakness), particularly if you have fever, a sick feeling or dark urine.

• Let your doctor know if you are pregnant or planning for pregnancy.

CiplaMed. Rosuvastatin+Aspirin. [Accessed 12 Apr. 2019] (online) Available from:

European Medicines Agency. Rosuvastatin+Acetylsalicylic acid. [Accessed 12 Apr. 2019] (online) Available from:

Rosuvastatin calcium. Carolina, Puerto Rico: IPR Pharmaceuticals, Inc.; 2003. [Accecssed 11 Apr. 2019] (online) Available from:

Aspirin. Maidenhead, Berkshire: Intrapharm Laboratories Limited; 2011 [revised 14 Jan. 2018]. [Accessed 12 Apr. 2019] (online) Available from: